Blog
Shaping the Future of Healthcare with Jiva.ai
Written by Marta Caldeira, 24th September 2020 Founded by Dr Manish Patel and Dr Chetan Kaher in 2019, British startup Jiva.ai is transforming the world of healthcare by providing a much-needed framework for the integration of different artificial intelligence (AI)...
My Personal Therapeutics: Turning Science Fiction into Science Reality
Written by Callum Oddy, 7th September 2020 As our knowledge of cancer and how to treat it evolves, scientists and medical professionals are searching for more ways to personalise and refine cancer treatments. My Personal Therapeutics is a company based in London that...
Pear Bio and the Ever-expanding World of Tailored Oncology
Written by Oscar Drury, 25th August 2020 In a world reliant upon standard patient care within oncology, Pear Bio looks to reform how pharmaceutical companies trial new drugs in addition to how doctors treat patients. This upheaval of the treatment status quo aims to...
Health Navigator Announces Major Rebranding to Reflect Growth and New Product Portfolio
PRESS RELEASE: For immediate release DATE: 13.08.2020 LOCATION: London, UK HEALTH-TECH COMPANY, HEALTH NAVIGATOR ANNOUNCES MAJOR REBRANDING TO REFLECT GROWTH AND NEW PRODUCT PORTFOLIO Health Navigator has announced a major rebranding to showcase the company’s...
NHSX Precision Medicine Case Study – Prof Phil Beales
Precision medicine encompasses predictive, preventive, personalised and participatory medicine (also termed P4 medicine). It is moving from the traditional one-size-fits-all form of medicine to more preventative, personalised, data-driven disease management model that...
Jiva.ai Awarded InnovateUK Funding For Liver Disease Early Diagnosis
PRESS RELEASE Summary Jiva.ai, in collaboration with the University of Manchester and major industrial players such as Roche Diagnostics, has been awarded a prestigious UKRI grant, which will accelerate the production of early diagnostic tools for Liver Disease. This...
My Personal Therapeutics awarded prestigious grant from Innovate UK
PRESS RELEASE My Personal Therapeutics awarded grant from Innovate UK to collaborate with the NIHR - London In Vitro Diagnostic Co-operative to provide personalised treatment to patients with Gastro-Intestinal Cancer London, July 15, 2020 – My Personal Therapeutics, a...
P4 2021 Programme Opening
PRESS RELEASEJuly 22, 2020 P4 Precision Medicine Accelerator opens 2021 programme applications * Please share with anyone in your network you feel may be interested in applying Powered by Barclays Eagle Labs, the P4 programme curates a unique ecosystem to support...
The journey of ElectronRx
Written by Marta Caldeira, 15th July 2020 Founded by Dr Bipin Patel, ElectronRx is a deep tech company working to develop novel diagnostic and therapeutic tools for the relief of human suffering. These include, among others, tools for the relief of heart failure and...
Motilent & Partners Receive Prestigious UKRI Funding
Crohn’s Disease is a chronic inflammatory condition of the intestine affecting people of all ages. There is an urgent need for technology to guide the use of powerful and expensive anti-inflammatory medications. Motilent has been awarded a prestigious UKRI grant to...